- Abigail Coursolle
- Alejandra Pavisich
- Alejandra Pavisich
- Alexis Robles-Fradet
- Alicia Emanuel
- Amanda Avery
- Amy Chen
- Andy DiAntonio
- Arielle Linsey
- Brian Brooks
- Candace Gibson
- Carly Myers
- Cassandra LaRose
- Cat Duffy
- Catherine McKee
- Cathren Cohen
- Charlie Blodnieks
- Charly Gilfoil
- Cheyenne Peters
- Christina Piecora
- Corey Davis
- Dania Douglas
- Daniel Young
- David Machledt
- Deanna Hartog
- Elizabeth Edwards
- Elizabeth G. Taylor
- Emma Parker-Newton
- Eskedar Girmash
- Fabiola De Liban
- Georgesula Ziama
- Geron Gadd
- Hannah Eichner
- Hayley Penan
- Héctor Hernández-Delgado
- Ian McDonald
- Jane Perkins
- Jasmine Young
- Jennifer Lav
- Joe McLean
- Jules Lutaba
- Kally Xu
- Kasey Nichols
- Kavisha Prajapati
- Kimberly Lewis
- Leonardo Cuello
- lhigashi
- Liz McCaman Taylor
- Madeline Morcelle
- Mara Youdelman
- Margaret Okakpu
- Maya Levin
- Michelle Lilienfeld
- Michelle Yiu
- Miriam Delaney Heard
- Mizue Suito
- Priscilla Huang
- Rachel Holtzman
- Rolonda Donelson
- Sarah Grusin
- Sarah Somers
- Skyler Rosellini
- Susan Berke Fogel
- T. Nancy Lam
- veng
- Walter Hsiang, MD
- Wayne Turner
- Zamir M. Brown
- Show all
- Alabama
- Alaska
- All United States
- Arizona
- Arkansas
- California
- Colorado
- Connecticut
- Delaware
- District of Columbia
- Florida
- Georgia
- Hawaii
- Idaho
- Illinois
- Indiana
- Iowa
- Kansas
- Kentucky
- Louisiana
- Maine
- Maryland
- Massachusetts
- Michigan
- Minnesota
- Mississippi
- Missouri
- Montana
- National
- Nebraska
- Nevada
- New Hampshire
- New Jersey
- New Mexico
- New York
- North Carolina
- North Dakota
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Utah
- Vermont
- Virginia
- Washington
- West Virginia
- Wisconsin
- Wyoming
- April 8, 2019
National Health Law Program Comments on HHS Safe Harbor Rule for Outpatient Prescription Drugs
Read moreThe U.S. Department of Health and Human Services (HHS) proposed new regulations that would remove safe harbor protections for prescription drug rebates. Currently, rebates paid by manufacturers to Medicare Part D plans and Medicaid managed care organizations (MCOs), including pharmacy benefit managers (PBMs) are shielded from federal anti-kickback laws.…
- December 18, 2018
Amicus Brief in Support of Maryland’s Anti-Price Gouging Law for Prescription Drugs
Read moreThe National Health Law Program filed an amicus brief with the United States Supreme Court asking it to review a 4th Circuit decision that struck down Maryland's anti-price gouging law for prescription drugs as unconstitutional. The brief focuses on the impact of high drug costs on low-income people and…
- December 14, 2018
Comments to the FDA Urging Approval of Over the Counter Naloxone
Read moreThe National Health Law Program strongly urges the Food and Drug Administration (FDA) to initiate the process of moving at least one naloxone product from prescription to over the counter (OTC) status. Naloxone, a safe and effective medication, reverses opioid overdose if given in time, but is often not…
- December 1, 2016
Fact Sheet: Utilization Controls for Medicaid Prescription Drugs
Abbi Coursolle Manual/ReportRead moreState Medicaid programs that elect to provide outpatient prescription drug coverage must cover all FDA-approved drugs that are offered by a manufacturer that agrees to provide rebates. Nevertheless, states have substantial discretion to use utilization control techniques to steer Medicaid beneficiaries toward or away from certain drugs, within limits.…
- November 30, 2016
Fact Sheet: Medicaid Outpatient Prescription Drugs
Read morePrescription drug coverage is an important facet of the Medicaid program. Although an optional benefit, all states cover outpatient prescription drugs in their Medicaid programs.This fact sheet provides an overview of Medicaid outpatient prescription drug coverage, including: federal minimum requirements, state restrictions on prescription drug access, and special rules…
- April 26, 2016
Covered California: 2016 Benefit Designs: Cost Sharing for Prescription Drugs & Tiered Network Designs
Abbi Coursolle and Kim Lewis LetterRead more